← Eichor
Condition: Lung Cancer Prevention Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lung Cancer Prevention

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
Phase 2 · 1 location(s) · Brown University · NCT06974604Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04789681Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Phase 1 · 5 location(s) · Tr1X, Inc. · NCT06462365PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
Phase N/A · 2 location(s) · M.D. Anderson Cancer Center · NCT02282969Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients U
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06634056InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT05189496Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06023212An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Pat
Phase 4 · 39 location(s) · AstraZeneca · NCT07357597PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
Phase 2 · 1 location(s) · Fujian Medical University Union Hospital · NCT05704166Prevention of Smoking Related Diseases
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06451029Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Canc
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07493304Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
NA · 1 location(s) · Scientific Institute San Raffaele · NCT06626178Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung
NA · 1 location(s) · Shanghai Chest Hospital · NCT07515027The Bern Rehab Registry
Phase N/A · 2 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06516172Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
NA · 1 location(s) · Medical University of South Carolina · NCT06451003Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Phase 3 · 1 location(s) · Pharmacosmos A/S · NCT07473128Akershus Cardiac Examination (ACE) 5 Study
NA · 1 location(s) · University Hospital, Akershus · NCT07301489Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese
NA · 1 location(s) · Shanghai University of Traditional Chinese Medicine · NCT05834413Mobile Lung Cancer Screening
Phase N/A · 2 location(s) · Hospices Civils de Lyon · NCT07015151RSV Vaccination in Immunocompromised Patients.
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06597916REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · 13 location(s) · Regeneron Pharmaceuticals · NCT07410117
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.